Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Sign up for alerts
  • About us
    • About Development
    • About the Node
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contacts
    • Subscriptions
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Development
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Development

  • Log in
Advanced search

RSS  Twitter  Facebook  YouTube 

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Sign up for alerts
  • About us
    • About Development
    • About the Node
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contacts
    • Subscriptions
    • Feedback
RESEARCH REPORT
TGF-α ligands can substitute for the neuregulin Vein in Drosophila development
Christina L. Austin, Sathiya N. Manivannan, Amanda Simcox
Development 2014 141: 4110-4114; doi: 10.1242/dev.110171
Christina L. Austin
Department of Molecular Genetics, Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sathiya N. Manivannan
Department of Molecular Genetics, Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Simcox
Department of Molecular Genetics, Ohio State University, Columbus, OH 43210, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: simcox.1@osu.edu
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Abstract

ErbB receptors, including the epidermal growth factor receptor (Egfr), are activated by EGF ligands to govern cell proliferation, survival, migration and differentiation. The different EGF-induced cell responses in development are regulated by deployment of multiple ligands. These inputs, however, engage only a limited number of intracellular pathways and are thought to elicit specific responses by regulating the amplitude or duration of the intracellular signal. The single Drosophila Egfr has four ligands: three of the TGF-α-type and a single neuregulin-like called vein (vn). Here, we used mutant combinations and gene replacement to determine the constraints of ligand specificity in development. Mutant analysis revealed extensive ligand redundancy in embryogenesis and wing development. Surprisingly, we found that the essential role of vn in development could be largely replaced by expression of any TGF-α ligand, including spitz (spi), in the endogenous vn pattern. vn mutants die as white undifferentiated pupae, but the rescued individuals showed global differentiation of adult body parts. Spi is more potent than Vn, and the best morphological rescue occurred when Spi expression was reduced to achieve an intracellular signaling level comparable to that produced by Vn. Our results show that the developmental repertoire of a strong ligand like Spi is flexible and at the appropriate level can emulate the activity of a weak ligand like Vn. These findings align with a model whereby cells respond similarly to an equivalent quantitative level of an intracellular signal generated by two distinct ligands regardless of ligand identity.

INTRODUCTION

Drosophila Egfr is the sole homolog of the vertebrate family that includes Egfr/ErbB1, neu/ErbB2, ErbB3 and ErbB4. Perturbation of the pathways, which have key roles in proliferation and differentiation during development and homeostasis, results in major developmental defects and problems in human health, including heart disease, schizophrenia and cancer [reviewed by, for example, Mei and Xiong (2008); Sanchez-Soria and Camenisch (2010); Yarden and Pines (2012)]. In mammals there are 11 EGF-like ligand genes (Groenen et al., 1994; Yarden, 2001). Drosophila has four EGF ligands, representing two major classes: the TGF-α ligands spitz (spi), gurken (grk) and Keren (Krn), and the neuregulin-like (NRG) ligand vein (vn) (Rutledge et al., 1992; Neuman-Silberberg and Schüpbach, 1993; Schnepp et al., 1996; Reich and Shilo, 2002; Urban et al., 2002).

Deployment of the four ligands, which operate both in distinct and in overlapping processes, contributes significantly to Drosophila development (Shilo, 2003). grk has a maternal role (Schüpbach, 1987), whereas spi has a major role in zygotic development and mutants die as embryos with ventral defects (Mayer and Nüsslein-Volhard, 1988). vn mutants have milder ventral defects and die at the pupal stage (Simcox, 1997). spi; vn double mutants have more than an additive phenotype, consistent with redundant ligand function (Schnepp et al., 1996). Further redundancy is suggested by the finding that Krn single mutants are viable and fertile adults, but functions in the eye, gut, ovary and brain are revealed when other ligands are compromised, animal physiology is altered or when Krn is expressed ectopically (Yang and Baker, 2003; McDonald et al., 2006; Brown et al., 2007; Jiang and Edgar, 2012; Rahn et al., 2013). Ectopic Krn expression can restore MAPK signaling in a spi mutant, thereby further demonstrating functional redundancy of the TGF-α ligands (Reich and Shilo, 2002). Some roles, by contrast, are ligand specific; for example, vn has a major role in wing development, whereas spi or Krn are not required (Simcox et al., 1987; Simcox, 1997; McDonald et al., 2006).

Here, we investigated the requirement for ligands by examining mutants lacking combinations of genes, and for ligand specificity by determining the ability of one ligand to replace another. We found that Egfr signaling is fully ligand dependent in embryogenesis and that all zygotic ligands play a role in embryo and wing development. Surprisingly, each of the TGF-α ligands could largely replace the essential role of vn in development when the active ligand was expressed in the vn pattern. Our results support the idea that stimulating the pathway to a particular level, and not the specific ligand bound, is important.

RESULTS AND DISCUSSION

Egfr-mediated embryonic patterning is dependent on function of all three zygotically active ligands

As single mutants, only spi and vn have defects in embryonic ventral patterning, and the double mutant is more severe (Schnepp et al., 1996) (Fig. 1A-C). Here, we found that Krn plays a redundant role with spi in embryonic cuticle patterning. spi; Krn double mutants had a similar phenotype to spi; vn double mutants (Fig. 1C,D). The triple mutant spi; vn; Krn was much more extreme than either double mutant and was indistinguishable from an Egfr null mutant (Fig. 1E,F). Both mutants lack ventral denticle belts and head structures. As expected, zygotic removal of the maternal ligand grk (spi, grk; vn, Krn) had no additional effect (Fig. 1G).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Redundant roles for EGF ligands in embryogenesis and wing development. (A) Wild-type embryo, with eight denticle belts (open circles). (B) spi2A mutant embryo, with eight narrow denticle belts (open circles), some of which are fused (*). (C) spi2A; vnL6 and (D) spi2A; Krn27 double mutant embryos, with a reduced number of denticle belts (open circles), fusions (*) and an anterior hole (arrow). (E) spi2A; vnL6, Krn27 triple mutant, (F) Egfr3F18/F24 receptor null and (G) spi2A, grkHF; vnL6, Krn27 quadruple mutant. The embryos are very short with no denticle belts and a large anterior hole (arrow). (H) Wild-type wing, with four major longitudinal veins (L2-5) and two crossveins, anterior crossvein (ACV) and posterior crossvein (PCV). (I) Krn27/9 wing with a normal vein pattern. (J) vn1/L6 hypomorphic mutant wing with loss of part of L4 and the ACV. Very few flies (7%, n=55) lack parts of L3. (K) vn1/L6, Krn27/9 wing, with more frequent (52%, n=64) loss of parts of L3. (L) spi2A/+; vn1/L6 wing, with similar vein loss as vn1/L6. (M) spi2A/+; vn1/L6, Krn27/9 wing, with frequent and more extensive loss of L3 (90% n=65).

The equivalent phenotypes of mutant embryos lacking the receptor or the ligands suggest that there is no signaling through Egfr in the absence of a ligand (Fig. 1E-G). Ligand-independent signaling has been reported for overexpression of Egfr in Drosophila and in mammalian cells, where the high levels of Egfr are thought to cause spontaneous dimerization and signaling (Schweitzer et al., 1995; Nagy et al., 2010; Endres et al., 2013). Our results suggest that, at the normal physiological level of the receptor in the fly embryo, all signaling is ligand dependent. The mutant combinations, however, suggest extensive redundancy between the ligands, consistent with roles that are only revealed when multiple ligands are compromised.

Wing vein patterning requires the function of all three zygotic ligands

vn has a role in patterning of the wing blade into territories of veins and interveins (Sturtevant and Bier, 1995; Simcox et al., 1996). No role has been found for spi or Krn in wing patterning (Simcox, 1997; Guichard et al., 1999; Nagaraj et al., 1999; McDonald et al., 2006). Reducing activity of Egfr or the protease Rhomboid (Rho), which is required to process the TGF-α ligands, causes vein loss, and rho vn double mutants lack all veins (Sturtevant et al., 1993; Sturtevant and Bier, 1995; Guichard et al., 2000; Ghiglione et al., 2002; Urban et al., 2002). This suggests that either or both spi and Krn could have redundant roles in wing development. We found that eliminating Krn function exacerbated the vein-loss phenotypes in vn mutants (Fig. 1H-K). Reducing spi levels had no observable effect on vn phenotypes (Fig. 1L; supplementary material Fig. S1). The most extreme phenotype resulted from reduction of function in all three genes (Fig. 1M), thereby suggesting that all three contribute to wing vein patterning.

The TGF-α ligands can replace the essential function of vn in development

The vn-GAL4 allele, generated as part of this study, has an amorphic phenotype and mutants die as white pupae with tiny wing disks (Fig. 2D-F; supplementary material Fig. S2). This allele, which is expressed in the endogenous vn pattern (supplementary material Fig. S3), allowed us to test whether ectopic activity of the TGF-α ligands rescued vn mutants.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Expression of rho rescues developmental abnormalities in vn mutants. rho encodes a protease that cleaves TGF-α ligands into an active form. (A) Wild-type adult fly, (B) wing disk and (C) wing. (D) vnL6/vn-Gal4 mutant pupa, (E) leg and wing disk and (F) higher magnification view of wing disk in E. vnL6/vn-Gal4 mutants die as pupae and have very small wing disks. (G) UAS-vn; vnL6/vn-Gal4 adult, (H) wing disk and (I) wing with a mild extra-vein phenotype consistent with overactivity of Egfr signaling (*). (J) UAS-rho; vnL6/vn-Gal4 pharate adult, (K) wing disk and (L) wing with fused L3 and L4 veins (arrow) and extra vein material (*). Wing disks were stained for Tsh (green) and Wg (red). Scale bars: 50 μm.

Expression of UAS-vn with vn-Gal4 (UAS-vn; vnL6/vn-Gal4) rescued ∼30% of vn mutants to adult flies with grossly normal patterning of the wing (Fig. 2G-I). Some extra vein material was observed, consistent with mild Egfr overactivity (Fig. 2I). Expression of rho (UAS-rho; vnL6/vn-Gal4) rescued ∼50% of vn mutants to pharate adults (differentiated adults that remain in the pupal case) with grossly normal wings (Fig. 3K,L). The region between veins L3 and L4 was fused and there was extra vein material, which correlates with the stripe of vn expression in the wing pouch (Simcox et al., 1996), suggesting that vn is uniquely suited to pattern this region correctly. vn is also required during the first and second instars for growth and global patterning of the early wing disk (Wang et al., 2000; Paul et al., 2013). Expression of rho replaced this function of vn and produced a disk of normal size and pattern (Fig. 2K). This suggests that one or more TGF-α ligands are present in the disk at the early stages, but remain in an inactive form because the processing factor rho is not normally expressed (Simcox, 1997; Zecca and Struhl, 2002).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Expression of any TGF-α ligand rescues developmental abnormalities in vn mutants. Expression of transgenes encoding the TGF-α ligands in the vn expression pattern rescues differentiation in vn mutant flies, including the body wall and wing. The flies are pharate adults that do not eclose. The wings have fused L3 and L4 veins and extra vein material (arrows). (A) UAS-sspi; Gal80TS; vnL6/vn-Gal4 pharate adult and (B) wing (27°C). (C) UAS-sKrn, vnL6/vn-Gal4 pharate adult and (D) wing (17°C). (E) UAS-sgrk, vnL6/vn-Gal4 pharate adult and (F) wing (17°C). Gal80TS is a repressor of Gal4 and reduces transgene expression (supplementary material Fig. S6).

Rho can cleave all three TGF-α ligands, and to determine whether expression of a particular ligand can replace the function of vn, we tested each ligand individually. Secreted forms were expressed to bypass the requirement for Rho (Urban et al., 2002). Expression of any TGF-α ligand rescued development of vn mutants to the pharate adult stage (Fig. 3; supplementary material Figs S4 and S5). The wings had regions of vein fusion and extra-vein material, characteristic of Egfr overactivity (Fig. 3).

The level of TGF-α transgene expression had a significant impact on the extent of rescue (supplementary material Fig. S4). To correlate rescue phenotypes with signaling, we examined in more detail the ability of secreted Spi (sSpi) to rescue vn mutants. Expression of sSpi at varying levels (supplementary material Fig. S6) produced different degrees of rescue in vn mutants (Fig. 4A). Adult head, leg and abdomen development were restored across a range of expression levels tested, suggesting that these body parts are relatively insensitive to the level of Egfr activity (Fig. 4A; supplementary material Figs S4 and S5). By contrast, a progression of rescue phenotypes was seen, as sSpi expression increased, from animals lacking all wing disk structures, to those with just wings and to optimal cases of animals with wings and a thoracic body wall (Fig. 4A I-III; supplementary material Fig. S7). At the highest Spi levels tested, the animals died as larvae (Fig. 4A IV). The Spi expression level that gave rise to optimal rescue correlated with a signaling output, as measured by MAPK phosphorylation (dpErk), which most closely matched to wild type (WT) (Fig. 4B,C). High levels of sSpi expression produced strongly elevated dpErk levels, which most likely accounted for the early death of these animals.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Optimal rescue of vn mutants occurs when transgenic spi expression restores signaling close to wild-type levels. (A) vn mutants die as pupae (left image). vn mutant flies rescued with increasing expression of sSpi are shown from left to right: UAS-sspi; Gal80TS/+; vnL6/vnGal4; at (I) 17°C, (II) 25°C and (III) 25-29°C. sSpi is toxic at a high expression level and individuals died as larvae (UAS-sspi; vnL6/vnGal4 17°C, see IV). (See also supplementary material Fig. S4.) (B) Western blot analysis and (C) quantification of dpErk (activated MAPK) levels relative to corresponding ERK levels, in the indicated genotypes (25°C). (wt): wild type. (-): vnL6/vnGal4; (spi): UAS-sspi, vnL6/vnGal4. (G80 spi): UAS-sspi; Gal80TS/+, vnL6/vnGal4. (vn): UAS-vn1.1; vnL6/vnGal4. (G80 vn): UAS-vn1.1; Gal80TS/+; vnL6/vnGal4. The quantification shown in C is the dpErk level normalized to the corresponding Erk level (n=6 replicates). Only the dpErk level following high sspi expression (UAS-sspi, vnL6/vnGal4) was significantly different than WT (*P<0.01). Statistical analysis was performed using a Wilcoxon rank-sum test. Gal80TS is a temperature-sensitive inhibitor of Gal4 and hence reduces transgene expression.

The intrinsic activity of an EGF ligand correlates with its biological effect; thus, at saturating concentrations, a ligand with high intrinsic activity has a higher maximum biologic effect than a ligand with low intrinsic activity (Wilson et al., 2012). Spi, therefore, appears to have a higher intrinsic activity than Vn, because at higher levels Spi exceeded the required biologic response and was toxic (Fig. 4; supplementary material Fig. S4). Spi also has a higher affinity than Vn (Alvarado et al., 2010). Low affinity might limit the access of Vn to the receptor through negative cooperativity, which proposes that, when the first ligand binds, a conformational change occurs that occludes the second site, rendering it accessible only to a high affinity ligand (Macdonald and Pike, 2008; Alvarado et al., 2010). The biological role of a low-affinity ligand like Vn might therefore be limited, because some cell responses require signaling levels that can be evoked only by high levels of a high-affinity ligand (Krall et al., 2011).

The Ig-domain is not required for the essential function of vn in development

Even in cases of the best morphological phenotypes, rescue of vn mutants by spi was incomplete because the flies did not eclose. This could reflect the artificial Gal4-UAS expression system. Alternatively, the Ig-domain found in Vn and the vertebrate NRGs could confer a unique function. In mice, Ig-containing NRG isoforms are essential (Kramer et al., 1996). A form of Vn lacking the Ig-domain (Vn-ΔIg) rescued vn mutants to adults, thus demonstrating that Ig containing forms are not essential for viability (supplementary material Fig. S8A). The wings of these flies were abnormal and had notched margins (supplementary material Fig. S8B), a phenotype that was also seen when this transgene was expressed in a wild-type fly (Donaldson et al., 2004). The Ig-domain could mediate the role of Vn in another pathway independent of its role in Egfr signaling. The wing phenotype is reminiscent of Notch or wingless mutants (Couso et al., 1994; Price et al., 1997; Wang et al., 2000), and the Vn Ig-domain physically interacts with Hedgehog co-receptors (Özkan et al., 2013), making any of these pathways candidates for interacting with Vn via the Ig domain.

We found a chimeric ligand, in which the Spi EGF-domain had been swapped with the Vn EGF-domain (Schnepp et al., 1998), rescued a vn mutant. These animals developed to pharate adults with pattern defects consistent with Egfr overactivity (supplementary material Fig. S8C,D). The phenotypes were similar to those seen following rescue by sSpi, showing that linking the Spi EGF-domain with an Ig-domain does not significantly alter its activity relative to the receptor.

Conclusions

In summary, our results show a high degree of functional redundancy among Egfr ligands and, moreover, that low levels of a strong TGF-α ligand like Spi can largely replace the developmental function of a weaker ligand like Vn. This is not reciprocal, however, because the lower biological activity of Vn limits its ability to replace or emulate the activity of Spi (Schnepp et al., 1998; Golembo et al., 1999; Donaldson et al., 2004; McDonald et al., 2006; Jiang and Edgar, 2009). The results support the idea that the appropriate cell response will occur regardless of ligand identity, provided a certain quantitative level of signaling is met. This conclusion is based on signaling resulting from activity of the EGF domain, which all Egfr ligands possess. Other unique domains, such as the Ig-domain found in Vn and the neuregulins, might facilitate engagement of other pathways and hence regulate different targets.

In the first example documenting distinct responses to different growth factors engaging MAPK signaling, the duration of signaling was shown to determine whether cells differentiated or proliferated (Marshall, 1995). The subsequent understanding of pathway architecture, including feedback loops, provides a deeper mechanistic view of how intracellular signaling through shared pathways produces different transcriptional responses (Nakakuki et al., 2010). Determining the amplitude and duration of signaling and specific transcriptional outputs induced by Spi and Vn will help shed light on potential differences between the ligands. These might account for the incomplete rescue of vn mutants by the TGF-α ligands and the patterning defects they induced in the wing. Nevertheless, the substantial rescue resulting from ligand substitution prompts the question of why multiple ligands have evolved in the fly when it seems that, in theory, fewer could suffice. Complex animals like the fly might have evolved a collection of high- and low-affinity ligands that are active in specific patterns and at different levels because this is more parsimonious than deploying a multitude of tissue-specific modulators to fine-tune the actions of fewer ligands.

MATERIALS AND METHODS

Fly stocks

The following mutant alleles were used: spi2A, grkHF, vn1, vnL6, Krn27, Krn9, Egfr3F18 and EgfrF24. The following transgenes were used: vn-Gal4, sd-Gal4, UAS-vn1.1 (Schnepp et al., 1996); UAS-vnΔIg (Donaldson et al., 2004); UAS-rho, UAS-mspi::GFP (Tsruya et al., 2002); UAS-sspi (Schweitzer et al., 1995); UAS-sKrn (Urban et al., 2002); UAS-sgrk (Queenan et al., 1999); UAS-vn::SpiEGF (Schnepp et al., 1998); UAS-spidsRNA (TRiP 34645 and 28387); UAS-vndsRNA (VDRC 50358 and 109437) and tubP-Gal80ts. Stocks with combinations of alleles were generated from single mutants, with the exception of a spi2A, grkHF/CyO stock that was a gift from Trudy Schüpbach (Princeton University, NJ, USA). The vn-Gal4 allele was obtained using the method of Sepp and Auld (1999). The vn-lacZ element (P[PZ, ry+] vnrF264, FBti0005059) was replaced with the P[GawB, w+] element in the PG142/FM7 stock (a gift from Norbert Perrimon, Harvard Medical School, Boston, MA, USA). The Gal4 element in the vn-Gal4 allele is in the 5′-UTR, 590 bp upstream of the open reading frame. Krn recombinants were genotyped by PCR, as homozygotes have no phenotype. Primers were used to amplify across the deleted region (8 kb in WT) and gave a band of ∼1 kb for Krn27 or ∼1.2 kb for Krn9 (F: AGTCGGCGGCCGTCAATTCG, R: TCCTGGGGCTCCT-TGCGTGT).

Protein analysis

Immunoblotting and immunohistochemistry were conducted using standard protocols with the following antibodies: anti-Phospho-p44/p42 MAPK (Cell Signaling Technology, #9106; 1:1000), anti-ERK 2 (Santa Cruz Biotechnology, K-23; 1:2000), anti-Tshirt (a gift from Steven Kerridge, Developmental Biology Institute of Marseille, France; 1:500), anti-GFP (Sigma, #G 1544; 1:1000) and anti-Wingless (Developmental Studies Hybridoma Bank, 4D4; 1:166).

Acknowledgements

We thank our colleagues Henri Jasper, Denise Montell, Norbert Perrimon, Trudi Schüpbach and Jessica Treisman, the Bloomington Stock Center for fly stocks, and Cassandra Jones and Adeline Ding, high school students at the time, for technical help.

Footnotes

  • Competing interests

    The authors declare no competing financial interests.

  • Author contributions

    All authors performed experiments, analyzed data, prepared the figures and wrote the manuscript.

  • Funding

    This work was funded by the National Science Foundation [IOS 090231 to A.S.], a Pelotonia Fellowship (C.L.A.) and a Seilhamer Fellowship (S.N.M.).

  • Supplementary material

    Supplementary material available online at http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.110171/-/DC1

  • Received March 16, 2014.
  • Accepted September 1, 2014.
  • © 2014. Published by The Company of Biologists Ltd

References

  1. ↵
    1. Alvarado, D.,
    2. Klein, D. E. and
    3. Lemmon, M. A.
    (2010). Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 142, 568-579. doi:10.1016/j.cell.2010.07.015
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Brown, K. E.,
    2. Kerr, M. and
    3. Freeman, M.
    (2007). The EGFR ligands Spitz and Keren act cooperatively in the Drosophila eye. Dev. Biol. 307, 105-113. doi:10.1016/j.ydbio.2007.04.025
    OpenUrlCrossRefPubMed
  3. ↵
    1. Couso, J. P.,
    2. Bishop, S. A. and
    3. Martinez Arias, A.
    (1994). The wingless signalling pathway and the patterning of the wing margin in Drosophila. Development 120, 621-636.
    OpenUrlAbstract
  4. ↵
    1. Donaldson, T.,
    2. Wang, S.-H.,
    3. Jacobsen, T. L.,
    4. Schnepp, B.,
    5. Price, J. and
    6. Simcox, A.
    (2004). Regulation of the Drosophila epidermal growth factor-ligand vein is mediated by multiple domains. Genetics 167, 687-698. doi:10.1534/genetics.103.019588
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Endres, N. F.,
    2. Das, R.,
    3. Smith, A. W.,
    4. Arkhipov, A.,
    5. Kovacs, E.,
    6. Huang, Y.,
    7. Pelton, J. G.,
    8. Shan, Y.,
    9. Shaw, D. E.,
    10. Wemmer, D. E. et al.
    (2013). Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152, 543-556. doi:10.1016/j.cell.2012.12.032
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Ghiglione, C.,
    2. Bach, E. A.,
    3. Paraiso, Y.,
    4. Carraway, K. L., III.,
    5. Noselli, S. and
    6. Perrimon, N.
    (2002). Mechanism of activation of the Drosophila EGF Receptor by the TGFalpha ligand Gurken during oogenesis. Development 129, 175-186.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Golembo, M.,
    2. Yarnitzky, T.,
    3. Volk, T. and
    4. Shilo, B.-Z.
    (1999). Vein expression is induced by the EGF receptor pathway to provide a positive feedback loop in patterning the Drosophila embryonic ventral ectoderm. Genes Dev. 13, 158-162. doi:10.1101/gad.13.2.158
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Groenen, L. C.,
    2. Nice, E. C. and
    3. Burgess, A. W.
    (1994). Structure-function relationships for the EGF/TGF-α family of mitogens. Growth Factors 11, 235-257. doi:10.3109/08977199409010997
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Guichard, A.,
    2. Biehs, B.,
    3. Sturtevant, M. A.,
    4. Wickline, L.,
    5. Chacko, J.,
    6. Howard, K. and
    7. Bier, E.
    (1999). Rhomboid and Star interact synergistically to promote EGFR/MAPK signaling during Drosophila wing vein development. Development 126, 2663-2676.
    OpenUrlAbstract
  10. ↵
    1. Guichard, A.,
    2. Roark, M.,
    3. Ronshaugen, M. and
    4. Bier, E.
    (2000). brother of rhomboid, a rhomboid-related gene expressed during early Drosophila oogenesis, promotes EGF-R/MAPK signaling. Dev. Biol. 226, 255-266. doi:10.1006/dbio.2000.9851
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Jiang, H. and
    2. Edgar, B. A.
    (2009). EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors. Development 136, 483-493. doi:10.1242/dev.026955
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Jiang, H. and
    2. Edgar, B. A.
    (2012). Intestinal stem cell function in Drosophila and mice. Curr. Opin. Genet. Dev. 22, 354-360. doi:10.1016/j.gde.2012.04.002
    OpenUrlCrossRefPubMed
  13. ↵
    1. Krall, J. A.,
    2. Beyer, E. M. and
    3. MacBeath, G.
    (2011). High- and low-affinity epidermal growth factor receptor-ligand interactions activate distinct signaling pathways. PLoS ONE 6, e15945. doi:10.1371/journal.pone.0015945
    OpenUrlCrossRefPubMed
  14. ↵
    1. Kramer, R.,
    2. Bucay, N.,
    3. Kane, D. J.,
    4. Martin, L. E.,
    5. Tarpley, J. E. and
    6. Theill, L. E.
    (1996). Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc. Natl. Acad. Sci. USA 93, 4833-4838. doi:10.1073/pnas.93.10.4833
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Macdonald, J. L. and
    2. Pike, L. J.
    (2008). Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proc. Natl. Acad. Sci. USA 105, 112-117. doi:10.1073/pnas.0707080105
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Marshall, C. J.
    (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185. doi:10.1016/0092-8674(95)90401-8
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Mayer, U. and
    2. Nüsslein-Volhard, C.
    (1988). A group of genes required for pattern formation in the ventral ectoderm of the Drosophila embryo. Genes Dev. 2, 1496-1511. doi:10.1101/gad.2.11.1496
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. McDonald, J. A.,
    2. Pinheiro, E. M.,
    3. Kadlec, L.,
    4. Schupbach, T. and
    5. Montell, D. J.
    (2006). Multiple EGFR ligands participate in guiding migrating border cells. Dev. Biol. 296, 94-103. doi:10.1016/j.ydbio.2006.04.438
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Mei, L. and
    2. Xiong, W.-C.
    (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437-452. doi:10.1038/nrn2392
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Nagaraj, R.,
    2. Pickup, A. T.,
    3. Howes, R.,
    4. Moses, K.,
    5. Freeman, M. and
    6. Banerjee, U.
    (1999). Role of the EGF receptor pathway in growth and patterning of the Drosophila wing through the regulation of vestigial. Development 126, 975-985.
    OpenUrlAbstract
  21. ↵
    1. Nagy, P.,
    2. Claus, J.,
    3. Jovin, T. M. and
    4. Arndt-Jovin, D. J.
    (2010). Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc. Natl. Acad. Sci. USA 107, 16524-16529. doi:10.1073/pnas.1002642107
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Nakakuki, T.,
    2. Birtwistle, M. R.,
    3. Saeki, Y.,
    4. Yumoto, N.,
    5. Ide, K.,
    6. Nagashima, T.,
    7. Brusch, L.,
    8. Ogunnaike, B. A.,
    9. Okada-Hatakeyama, M. and
    10. Kholodenko, B. N.
    (2010). Ligand-specific c-Fos expression emerges from the spatiotemporal control of ErbB network dynamics. Cell 141, 884-896. doi:10.1016/j.cell.2010.03.054
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Neuman-Silberberg, F. S. and
    2. Schüpbach, T.
    (1993). The Drosophila dorsoventral patterning gene gurken produces a dorsally localized RNA and encodes a TGF alpha-like protein. Cell 75, 165-174. doi:10.1016/0092-8674(93)90688-M
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Özkan, E.,
    2. Carrillo, R. A.,
    3. Eastman, C. L.,
    4. Weiszmann, R.,
    5. Waghray, D.,
    6. Johnson, K. G.,
    7. Zinn, K.,
    8. Celniker, S. E. and
    9. Garcia, K. C.
    (2013). An extracellular interactome of immunoglobulin and LRR proteins reveals receptor-ligand networks. Cell 154, 228-239. doi:10.1016/j.cell.2013.06.006
    OpenUrlCrossRefPubMed
  25. ↵
    1. Paul, L.,
    2. Wang, S.-H.,
    3. Manivannan, S. N.,
    4. Bonanno, L.,
    5. Lewis, S.,
    6. Austin, C. L. and
    7. Simcox, A.
    (2013). Dpp-induced Egfr signaling triggers postembryonic wing development in Drosophila. Proc. Natl. Acad. Sci. USA 110, 5058-5063. doi:10.1073/pnas.1217538110
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Price, J. V.,
    2. Savenye, E. D.,
    3. Lum, D. and
    4. Breitkreutz, A.
    (1997). Dominant enhancers of Egfr in Drosophila melanogaster: genetic links between the Notch and Egfr signaling pathways. Genetics 147, 1139-1153.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Queenan, A. M.,
    2. Barcelo, G.,
    3. Van Buskirk, C. and
    4. Schüpbach, T.
    (1999). The transmembrane region of Gurken is not required for biological activity, but is necessary for transport to the oocyte membrane in Drosophila. Mech. Dev. 89, 35-42. doi:10.1016/S0925-4773(99)00196-3
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Rahn, T.,
    2. Leippe, M.,
    3. Roeder, T. and
    4. Fedders, H.
    (2013). EGFR signaling in the brain is necessary for olfactory learning in Drosophila larvae. Learn. Mem. 20, 194-200. doi:10.1101/lm.029934.112
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Reich, A. and
    2. Shilo, B.-Z.
    (2002). Keren, a new ligand of the Drosophila epidermal growth factor receptor, undergoes two modes of cleavage. Embo. J. 21, 4287-4296. doi:10.1093/emboj/cdf439
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Rutledge, B. J.,
    2. Zhang, K.,
    3. Bier, E.,
    4. Jan, Y. N. and
    5. Perrimon, N.
    (1992). The Drosophila spitz gene encodes a putative EGF-like growth factor involved in dorsal-ventral axis formation and neurogenesis. Genes Dev. 6, 1503-1517. doi:10.1101/gad.6.8.1503
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Sanchez-Soria, P. and
    2. Camenisch, T. D.
    (2010). ErbB signaling in cardiac development and disease. Semin. Cell Dev. Biol. 21, 929-935. doi:10.1016/j.semcdb.2010.09.011
    OpenUrlCrossRefPubMed
  32. ↵
    1. Schnepp, B.,
    2. Grumbling, G.,
    3. Donaldson, T. and
    4. Simcox, A.
    (1996). Vein is a novel component in the Drosophila epidermal growth factor receptor pathway with similarity to the neuregulins. Genes Dev. 10, 2302-2313. doi:10.1101/gad.10.18.2302
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Schnepp, B.,
    2. Donaldson, T.,
    3. Grumbling, G.,
    4. Ostrowski, S.,
    5. Schweitzer, R.,
    6. Shilo, B.-Z. and
    7. Simcox, A.
    (1998). EGF domain swap converts a Drosophila EGF-receptor activator into an inhibitor. Genes Dev. 12, 908-913. doi:10.1101/gad.12.7.908
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Schüpbach, T.
    (1987). Germ line and soma cooperate during oogenesis to establish the dorsoventral pattern of egg shell and embryo in Drosophila melanogaster. Cell 49, 699-707. doi:10.1016/0092-8674(87)90546-0
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Schweitzer, R.,
    2. Shaharabany, M.,
    3. Seger, R. and
    4. Shilo, B. Z.
    (1995). Secreted Spitz triggers the DER signaling pathway and is a limiting component in embryonic ventral ectoderm determination. Genes Dev. 9, 1518-1529. doi:10.1101/gad.9.12.1518
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Sepp, K. J. and
    2. Auld, V. J.
    (1999). Conversion of lacZ enhancer trap lines to GAL4 lines using targeted transposition in Drosophila melanogaster. Genetics 151, 1093-1101.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Shilo, B.-Z.
    (2003). Signaling by the Drosophila epidermal growth factor receptor pathway during development. Exp. Cell Res. 284, 140-149. doi:10.1016/S0014-4827(02)00094-0
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    1. Simcox, A.
    (1997). Differential requirement for EGF-like ligands in Drosophila wing development. Mech. Dev. 62, 41-50. doi:10.1016/S0925-4773(96)00643-0
    OpenUrlCrossRefPubMed
  39. ↵
    1. Simcox, A. A.,
    2. Wurst, G.,
    3. Hersperger, E. and
    4. Shearn, A.
    (1987). The defective dorsal discs gene of Drosophila is required for the growth of specific imaginal discs. Dev. Biol. 122, 559-567. doi:10.1016/0012-1606(87)90319-8
    OpenUrlCrossRefPubMed
  40. ↵
    1. Simcox, A. A.,
    2. Grumbling, G.,
    3. Schnepp, B.,
    4. Bennington-Mathias, C.,
    5. Hersperger, E. and
    6. Shearn, A.
    (1996). Molecular, phenotypic, and expression analysis of vein, a gene required for growth of the Drosophila wing disc. Dev. Biol. 177, 475-489. doi:10.1006/dbio.1996.0179
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Sturtevant, M. A. and
    2. Bier, E.
    (1995). Analysis of the genetic hierarchy guiding wing vein development in Drosophila. Development 121, 785-801.
    OpenUrlAbstract
  42. ↵
    1. Sturtevant, M. A.,
    2. Roark, M. and
    3. Bier, E.
    (1993). The Drosophila rhomboid gene mediates the localized formation of wing veins and interacts genetically with components of the EGF-R signaling pathway. Genes Dev. 7, 961-973. doi:10.1101/gad.7.6.961
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Tsruya, R.,
    2. Schlesinger, A.,
    3. Reich, A.,
    4. Gabay, L.,
    5. Sapir, A. and
    6. Shilo, B.-Z.
    (2002). Intracellular trafficking by Star regulates cleavage of the Drosophila EGF receptor ligand Spitz. Genes Dev. 16, 222-234. doi:10.1101/gad.214202
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Urban, S.,
    2. Lee, J. R. and
    3. Freeman, M.
    (2002). A family of Rhomboid intramembrane proteases activates all Drosophila membrane-tethered EGF ligands. EMBO J. 21, 4277-4286. doi:10.1093/emboj/cdf434
    OpenUrlAbstract
  45. ↵
    1. Wang, S.-H.,
    2. Simcox, A. and
    3. Campbell, G.
    (2000). Dual role for Drosophila epidermal growth factor receptor signaling in early wing disc development. Genes Dev. 14, 2271-2276. doi:10.1101/gad.827000
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Wilson, K. J.,
    2. Mill, C.,
    3. Lambert, S.,
    4. Buchman, J.,
    5. Wilson, T. R.,
    6. Hernandez-Gordillo, V.,
    7. Gallo, R. M.,
    8. Ades, L. M. C.,
    9. Settleman, J. and
    10. Riese, D. J., II.
    . (2012). EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors 30, 107-116. doi:10.3109/08977194.2011.649918
    OpenUrlCrossRefPubMedWeb of Science
  47. ↵
    1. Yang, L. and
    2. Baker, N. E.
    (2003). Cell cycle withdrawal, progression, and cell survival regulation by EGFR and its effectors in the differentiating Drosophila eye. Dev. Cell 4, 359-369. doi:10.1016/S1534-5807(03)00059-5
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    1. Yarden, Y.
    (2001). The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 37 Suppl. 4, S3-S8. doi:10.1016/S0959-8049(01)00230-1
    OpenUrlCrossRef
  49. ↵
    1. Yarden, Y. and
    2. Pines, G.
    (2012). The ERBB network: at last, cancer therapy meets systems biology. Nat. Rev. Cancer 12, 553-563. doi:10.1038/nrc3309
    OpenUrlCrossRefPubMedWeb of Science
  50. ↵
    1. Zecca, M. and
    2. Struhl, G.
    (2002). Control of growth and patterning of the Drosophila wing imaginal disc by EGFR-mediated signaling. Development 129, 1369-1376.
    OpenUrlPubMedWeb of Science
View Abstract
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

Keywords

  • Vein
  • Spitz
  • EGFR
  • Neuregulin
  • Wing
  • Drosophila

 Download PDF

Email

Thank you for your interest in spreading the word on Development.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
TGF-α ligands can substitute for the neuregulin Vein in Drosophila development
(Your Name) has sent you a message from Development
(Your Name) thought you would like to see the Development web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
RESEARCH REPORT
TGF-α ligands can substitute for the neuregulin Vein in Drosophila development
Christina L. Austin, Sathiya N. Manivannan, Amanda Simcox
Development 2014 141: 4110-4114; doi: 10.1242/dev.110171
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
RESEARCH REPORT
TGF-α ligands can substitute for the neuregulin Vein in Drosophila development
Christina L. Austin, Sathiya N. Manivannan, Amanda Simcox
Development 2014 141: 4110-4114; doi: 10.1242/dev.110171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Abstract
    • INTRODUCTION
    • RESULTS AND DISCUSSION
    • MATERIALS AND METHODS
    • Acknowledgements
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • PHOSPHORYLETHANOLAMINE CYTIDYLYLTRANSFERASE 1 modulates flowering in a florigen-independent manner by regulating SVP
  • Morphogenesis is transcriptionally coupled to neurogenesis during peripheral olfactory organ development
  • CNS macrophages differentially rely on an intronic Csf1r enhancer for their development
Show more RESEARCH REPORTS

Similar articles

Other journals from The Company of Biologists

Journal of Cell Science

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

Kathryn Virginia Anderson (1952-2020)

Developmental geneticist Kathryn Anderson passed away at home on 30 November 2020. Tamara Caspary, a former postdoc and friend, remembers Kathryn and her remarkable contribution to developmental biology.


Zooming into 2021

In a new Editorial, Editor-in-Chief James Briscoe and Executive Editor Katherine Brown reflect on the triumphs and tribulations of the last 12 months, and look towards a hopefully calmer and more predictable year.


Read & Publish participation extends worldwide

Over 60 institutions in 12 countries are now participating in our Read & Publish initiative. Here, James Briscoe explains what this means for his institution, The Francis Crick Institute. Find out more and view our full list of participating institutions.


Upcoming special issues

Imaging Development, Stem Cells and Regeneration
Submission deadline: 30 March 2021
Publication: mid-2021

The Immune System in Development and Regeneration
Guest editors: Florent Ginhoux and Paul Martin
Submission deadline: 1 September 2021
Publication: Spring 2022

Both special issues welcome Review articles as well as Research articles, and will be widely promoted online and at key global conferences.


Development presents...

Our successful webinar series continues into 2021, with early-career researchers presenting their papers and a chance to virtually network with the developmental biology community afterwards. Sign up to join our next session:

10 February
Time: 13:00 (GMT)
Chaired by: preLights

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Sign up for alerts

About us

  • About Development
  • About the Node
  • Editors and board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • Biology Open transfer

Journal info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact Development
  • Subscriptions
  • Advertising
  • Feedback

 Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992